➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Mallinckrodt
McKesson
Colorcon
Moodys
Merck

Last Updated: September 30, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Surotomycin

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the drug development status for Surotomycin?

Surotomycin is an investigational drug.

There have been 4 clinical trials for Surotomycin. The most recent clinical trial was a Phase 3 trial, which was initiated on May 1st 2012.

The most common disease conditions in clinical trials are Diarrhea and [disabled in preview]. The leading clinical trial sponsors are Merck Sharp & Dohme Corp., Cubist Pharmaceuticals LLC, and [disabled in preview].

There is one US patent protecting this investigational drug and thirty-one international patents.

Recent Clinical Trials for Surotomycin
TitleSponsorPhase
Study of CB-183,315 in Patients With Clostridium Difficile Associated DiarrheaCubist Pharmaceuticals LLCPhase 3
A Study of CB-183,315 in Patients With Clostridium Difficile Associated DiarrheaCubist Pharmaceuticals LLCPhase 3
A Study of Ascending Multiple Doses of Oral Surotomycin in Healthy Participants (MK-4261-009)Merck Sharp & Dohme Corp.Phase 1

See all Surotomycin clinical trials

Clinical Trial Summary for Surotomycin

Top disease conditions for Surotomycin
Top clinical trial sponsors for Surotomycin

See all Surotomycin clinical trials

International Patents for Surotomycin

Drugname Country Document Number Estimated Expiration Related US Patent
Surotomycin Argentina 074833 2028-12-22   Start Trial
Surotomycin Australia 2009330245 2028-12-22   Start Trial
Surotomycin Brazil PI0923567 2028-12-22   Start Trial
Surotomycin Canada 2747965 2028-12-22   Start Trial
Surotomycin China 102325787 2028-12-22   Start Trial
Surotomycin Cyprus 1114883 2028-12-22   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Mallinckrodt
McKesson
Colorcon
Moodys
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.